Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1961 1
1962 1
1963 1
1964 1
1965 2
1967 1
1968 2
1969 1
1970 4
1971 9
1972 7
1973 3
1974 5
1975 5
1976 7
1977 6
1978 9
1979 16
1980 12
1981 16
1982 10
1983 10
1984 8
1985 11
1986 8
1987 14
1988 13
1989 18
1990 13
1991 8
1992 7
1993 6
1994 8
1995 9
1996 14
1997 12
1998 7
1999 10
2000 12
2001 5
2002 21
2003 27
2004 15
2005 21
2006 21
2007 20
2008 36
2009 46
2010 63
2011 54
2012 59
2013 50
2014 51
2015 56
2016 62
2017 48
2018 54
2019 62
2020 61
2021 72
2022 61
2023 52
2024 63

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,235 results

Results by year

Filters applied: . Clear all
Page 1
Current clinical management of gastrointestinal stromal tumor.
Akahoshi K, Oya M, Koga T, Shiratsuchi Y. Akahoshi K, et al. Among authors: oya m. World J Gastroenterol. 2018 Jul 14;24(26):2806-2817. doi: 10.3748/wjg.v24.i26.2806. World J Gastroenterol. 2018. PMID: 30018476 Free PMC article. Review.
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Saad F, Clarke NW, Oya M, Shore N, Procopio G, Guedes JD, Arslan C, Mehra N, Parnis F, Brown E, Schlürmann F, Joung JY, Sugimoto M, Sartor O, Liu YZ, Poehlein C, Barker L, Del Rosario PM, Armstrong AJ. Saad F, et al. Among authors: oya m. Lancet Oncol. 2023 Oct;24(10):1094-1108. doi: 10.1016/S1470-2045(23)00382-0. Epub 2023 Sep 12. Lancet Oncol. 2023. PMID: 37714168 Clinical Trial.
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, Gümüş M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Schutz FA, Park SH, Nosov DA, Porta C, Lee JL, Garcia-Del-Muro X, Biscaldi E, Manneh Kopp R, Oya M, He L, Wang A, Perini RF, Vickery D, Albiges L, Rini B; LITESPARK-005 Investigators. Choueiri TK, et al. Among authors: oya m. N Engl J Med. 2024 Aug 22;391(8):710-721. doi: 10.1056/NEJMoa2313906. N Engl J Med. 2024. PMID: 39167807 Clinical Trial.
Editorial Comment.
Yazawa S, Oya M, Nakajima Y. Yazawa S, et al. Among authors: oya m. J Urol. 2019 Nov;202(5):1000. doi: 10.1097/01.JU.0000578560.21169.3f. Epub 2019 Oct 9. J Urol. 2019. PMID: 31339421 No abstract available.
Modified Measles.
Oya M, Hakozaki Y, Kubota T. Oya M, et al. Intern Med. 2017;56(7):885. doi: 10.2169/internalmedicine.56.7639. Epub 2017 Apr 1. Intern Med. 2017. PMID: 28381764 Free PMC article. No abstract available.
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study.
Grünwald V, Powles T, Kopyltsov E, Kozlov V, Alonso-Gordoa T, Eto M, Hutson T, Motzer R, Winquist E, Maroto P, Keam B, Procopio G, Wong S, Melichar B, Rolland F, Oya M, Rodriguez-Lopez K, Saito K, McKenzie J, Porta C. Grünwald V, et al. Among authors: oya m. Eur Urol Oncol. 2023 Aug;6(4):437-446. doi: 10.1016/j.euo.2023.01.010. Epub 2023 Jan 29. Eur Urol Oncol. 2023. PMID: 36720658 Free PMC article. Clinical Trial.
Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.
Iwahashi N, Umakoshi H, Seki T, Gomez-Sanchez CE, Mukai K, Suematsu M, Umezawa Y, Oya M, Kosaka T, Seki M, Suzuki Y, Horiuchi Y, Ogawa Y, Nishimoto K. Iwahashi N, et al. Among authors: oya m. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2439-2448. doi: 10.1210/clinem/dgac394. J Clin Endocrinol Metab. 2022. PMID: 35796577 Free PMC article.
Primary intratesticular leiomyosarcoma.
Yoshimine S, Kono H, Nakagawa K, Kikuchi E, Miyajima A, Kameyama K, Mukai M, Oya M. Yoshimine S, et al. Among authors: oya m. Can Urol Assoc J. 2009 Dec;3(6):E74-6. doi: 10.5489/cuaj.1184. Can Urol Assoc J. 2009. PMID: 20019958 Free PMC article.
Experience-related enhancements in striatal temporal encoding.
Bruce RA, Weber MA, Volkman RA, Oya M, Emmons EB, Kim Y, Narayanan NS. Bruce RA, et al. Among authors: oya m. Eur J Neurosci. 2021 Aug;54(3):5063-5074. doi: 10.1111/ejn.15344. Epub 2021 Jun 29. Eur J Neurosci. 2021. PMID: 34097793 Free PMC article.
Ureteral metastasis from prostate cancer.
Hongo H, Kosaka T, Yoshimine S, Oya M. Hongo H, et al. Among authors: oya m. BMJ Case Rep. 2014 Aug 28;2014:bcr2014206736. doi: 10.1136/bcr-2014-206736. BMJ Case Rep. 2014. PMID: 25168825 Free PMC article. Review.
1,235 results